IMBRUVICA Now Approved in the U.S. for Patients with Chronic Lymphocytic Leukemia Who Have Received At Least One Prior Therapy HORSHAM, Pa., Feb. 12, 2014 /PRNewswire/ -- Janssen Biotech, Inc. ["Janssen"] today announced the U.S. Food and Drug Administration has approved IMBRUVICA capsules for the treatment of patients with chronic lymphocytic ... (more)
http://ift.tt/1j5BbLl
http://ift.tt/1j5BbLl
No comments:
Post a Comment